AG
AgomAb Therapeutics N.V. American Depositary Shares
AGMB · NASDAQ
$11.70 -4.57% (-$0.56)
1M -5.07%
Valuation
-
N/A P/E N/A
EV/FFO N/A
EV/EBITDA N/A
Growth
-
N/A EPS growth N/A
Book val. growth N/A
Rev. growth N/A
Profitability
-
N/A Gross margin N/A
FCF margin N/A
Net margin N/A
Quality
-
N/A ROIC N/A
Asset turnover N/A
ROE N/A
Debt
-
N/A Debt/Equity N/A
Debt/Assets N/A
Current ratio N/A
Stability
20 /100
Unstable Beta 1.66x
Rev. volatility N/A
Profitable years N/A
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about AGMB
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Tim Knotnerus
Employees
62
Headquarters
Antwerp
Upcoming events
03 MAR
Earnings
Upcoming earnings report